ReviewCirculation research2019

Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association.

Gary Gintant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.